Humana Inc. | Large-cap | Healthcare

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 32.1B
Net Income 1.2B 3.87%

Balance Sheet Metrics

Total Assets 50.9B
Total Liabilities 33.1B
Shareholders Equity 17.8B
Debt to Equity 1.86

Cash Flow Metrics

Operating Cash Flow 66.0M
Free Cash Flow 236.0M

Revenue & Profitability Trend

Humana Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i117.8B106.4B92.9B83.1B77.2B
Cost of Goods Sold i-----
Gross Profit i-----
Gross Margin % i0.0%0.0%0.0%0.0%0.0%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i----10.1B
Other Operating Expenses i13.9B13.3B12.7B9.6B10.2B
Total Operating Expenses i13.9B13.3B12.7B9.6B20.2B
Operating Income i-----
Operating Margin % i0.0%0.0%0.0%0.0%0.0%
Non-Operating Items
Interest Income i-----
Interest Expense i660.0M493.0M401.0M326.0M283.0M
Other Non-Operating Income-----
Pre-tax Income i1.7B3.4B3.6B3.4B4.6B
Income Tax i413.0M836.0M762.0M485.0M1.3B
Effective Tax Rate % i24.0%24.7%21.4%14.5%28.4%
Net Income i1.2B2.5B2.8B2.9B3.4B
Net Margin % i1.0%2.3%3.0%3.5%4.4%
Key Metrics
EBITDA i-----
EPS (Basic) i$10.01$20.09$22.20$22.79$25.47
EPS (Diluted) i$9.98$20.00$22.08$22.67$25.31
Basic Shares Outstanding i120571000123866000126419000128687998132198998
Diluted Shares Outstanding i120571000123866000126419000128687998132198998

Income Statement Trend

Humana Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i2.2B4.7B5.1B3.4B4.7B
Short-term Investments i18.2B16.6B13.9B13.2B12.6B
Accounts Receivable i2.7B2.0B1.7B1.8B1.1B
Inventory i-----
Other Current Assets-----
Total Current Assets i-----
Non-Current Assets
Property, Plant & Equipment i-----
Goodwill i20.7B20.8B20.0B24.8B9.2B
Intangible Assets i1.4B1.7B1.8B2.6B329.0M
Long-term Investments-----
Other Non-Current Assets-----
Total Non-Current Assets i-----
Total Assets i46.5B----
Liabilities
Current Liabilities
Accounts Payable i15.7B16.8B14.5B12.8B12.2B
Short-term Debt i577.0M1.4B3.2B2.0B600.0M
Current Portion of Long-term Debt-----
Other Current Liabilities-----
Total Current Liabilities i-----
Non-Current Liabilities
Long-term Debt i11.1B10.2B7.9B10.5B6.1B
Deferred Tax Liabilities i-----
Other Non-Current Liabilities-----
Total Non-Current Liabilities i-----
Total Liabilities i30.0B----
Equity
Common Stock i33.0M33.0M33.0M33.0M33.0M
Retained Earnings i28.3B27.5B25.5B23.1B20.5B
Treasury Stock i14.4B13.7B12.2B10.2B9.9B
Other Equity-----
Total Shareholders Equity i16.4B16.3B15.4B16.1B13.7B
Key Metrics
Total Debt i11.7B11.7B11.1B12.5B6.7B
Working Capital i00000

Balance Sheet Composition

Humana Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i1.2B2.5B2.8B2.9B3.4B
Depreciation & Amortization i-----
Stock-Based Compensation i207.0M175.0M216.0M180.0M181.0M
Working Capital Changes i154.0M81.0M534.0M-556.0M2.1B
Operating Cash Flow i1.5B2.7B3.5B2.6B5.9B
Investing Activities
Capital Expenditures i-568.0M-794.0M-1.1B-1.3B-964.0M
Acquisitions i-89.0M-233.0M2.4B-4.2B-709.0M
Investment Purchases i-8.2B-7.6B-6.0B-7.2B-9.1B
Investment Sales i6.4B5.1B3.8B6.1B7.7B
Investing Cash Flow i-3.0B-3.5B-1.0B-6.6B-3.1B
Financing Activities
Share Repurchases i-817.0M-1.6B-2.1B-79.0M-1.8B
Dividends Paid i-431.0M-431.0M-392.0M-354.0M-323.0M
Debt Issuance i2.2B2.5B2.0B5.5B2.1B
Debt Repayment i-2.0B-2.4B-3.4B-2.1B-1.4B
Financing Cash Flow i-3.8B-956.0M-2.3B3.0B-2.0B
Free Cash Flow i2.4B3.0B3.4B920.0M4.7B
Net Change in Cash i-5.3B-1.8B226.0M-928.0M915.0M

Cash Flow Trend

Humana Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 21.59
Forward P/E 16.75
Price to Book 1.86
Price to Sales 0.28
PEG Ratio 16.75

Profitability Ratios

Profit Margin 1.28%
Operating Margin 3.58%
Return on Equity 9.03%
Return on Assets 4.69%

Financial Health

Current Ratio 1.95
Debt to Equity 70.63
Beta 0.45

Per Share Data

EPS (TTM) $13.06
Book Value per Share $151.61
Revenue per Share $1,021.52

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
hum33.9B21.591.869.03%1.28%70.63
UnitedHealth 244.5B11.692.5821.65%5.04%75.58
CVS Health 87.0B19.111.125.88%1.18%106.67
Cigna 79.2B16.281.9713.18%1.92%76.10
Elevance Health 69.7B13.141.5912.42%2.83%68.84
Centene 14.0B6.920.517.44%1.29%63.91

Financial data is updated regularly. All figures are in the company's reporting currency.